Skip to main content
Top

Clinical and Translational Oncology

Issue 8/2016

Content (14 Articles)

Review Article

Review: circulating tumor cells in the practice of breast cancer oncology

R. Ramos-Medina, F. Moreno, S. Lopez-Tarruella, M. del Monte-Millán, I. Márquez-Rodas, E. Durán, Y. Jerez, J. A. Garcia-Saenz, I. Ocaña, S. Andrés, T. Massarrah, M. González-Rivera, M. Martin

Review Article

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

E. Grande, J. Santamaría Sandi, J. Capdevila, E. Navarro González, C. Zafón Llopis, T. Ramón y Cajal Asensio, J. M. Gómez Sáez, P. Jiménez-Fonseca, G. Riesco-Eizaguirre, J. C. Galofré

Research Article

ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker

M.- J. Zhang, C.- Z. Zhang, W.- J. Du, X.- Z. Yang, Z.- P. Chen

Research Article

Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer

J.-G. Zhu, D.-B. Yuan, W.-H. Chen, Z.-D. Han, Y.-X. Liang, G. Chen, X. Fu, Y.-K. Liang, G.-X. Chen, Z.-L. Sun, Z.-Z. Liu, J.-H. Chen, F.-N. Jiang, W.-D. Zhong

Research Article

Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling

Z. Zhu, H. Zhang, F. Lang, G. Liu, D. Gao, B. Li, Y. Liu

Research Article

Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer

A. Lafuente-Sanchis, Á. Zúñiga, J. M. Galbis, A. Cremades, M. Estors, N. J. Martínez-Hernández, J. Carretero

Research Article

GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status

P. Pérez-Segura, R. Manneh, I. Ceballos, A. García, M. Benavides, J. Fuster, M. A. Vaz, J. M. Cano, J. P. Berros, M. Covela, V. Moreno, T. Quintanar, J. M. García Bueno, I. Fernández, J. Sepúlveda

Research Article

Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer

M. Martín, A. Hinojar, L. Cerezo, J. García, M. Lopez, J. Prada, A. Marín, C. Gamallo

Research Article

Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance

L. Yang, Q. Xu, H. Xie, G. Gu, J. Jiang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine